Immuneering (IMRX) Operating Margin (2020 - 2022)
Immuneering (IMRX) posted quarterly Operating Margin of 3073627.91% for Q4 2022, down 306776489.0% year-over-year from N/an in Q4 2021, and down 8844.84% quarter-over-quarter from 34362.04% in Q3 2022.
Powered by 
Analysis
Immuneering (IMRX) Operating Margin (2020 - 2022) Analysis & Trends
Immuneering's Operating Margin history runs 3 years deep, the most recent figure standing at 3073627.91% for Q4 2022.
- In Q4 2022, Operating Margin fell 306776489.0% year-over-year to 3073627.91%; the TTM figure through Sep 2023 stood at 12328770.77% (down 1231911324.0% YoY), while the FY2022 annual figure was 16325.77%, down 1469661.0% from the prior year.
- Operating Margin for Q4 2022 stood at 3073627.91%, down from 34362.04% in the prior quarter.
- The five-year high for Operating Margin was 644.66% in Q3 2020, with the low at 3073627.91% in Q4 2022.
- The 3-year median for Operating Margin is 1772.01% (2021), against an average of 285392.02%.
- The sharpest annual moves came in 2021 and 2022: Operating Margin plunged 46060 bps in 2021, then slumped 306776489 bps in 2022.
- Immuneering's Operating Margin stood at 877.56% in 2020, then plunged by 568 bps to 5863.02% in 2021, then tumbled by 52324 bps to 3073627.91% in 2022.
- Business Quant data shows IMRX's Operating Margin at 3073627.91% in Q4 2022, 34362.04% in Q3 2022, and 12334.43% in Q2 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 32.54% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -562.07% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 19.06% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 17.93% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 19.75% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.36% |
| 10 | Immuneering | 313.13 Mn | 313.13 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | -3,073,627.91% |
| Sep 30, 2022 | -34,362.04% |
| Jun 30, 2022 | -12,334.43% |
| Mar 31, 2022 | -7,036.37% |
| Dec 31, 2021 | -5,863.02% |
| Sep 30, 2021 | -1,772.01% |
| Jun 30, 2021 | -1,210.67% |
| Mar 31, 2021 | -833.47% |
| Dec 31, 2020 | -877.56% |
| Sep 30, 2020 | -644.66% |
| Jun 30, 2020 | -750.08% |